ReviewFrontiers in oncology2026
Physicochemical design of nanobiomaterials in oncology: structure-to-function principles for sequential transport and delivery.
Review in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The physicochemical properties of nanobiomaterials (NBM) have enabled nanomedicine platforms capable of addressing major therapeutic challenges in oncology, including poor bioavailability, systemic toxicity, limited tumor accumulation, and off-target effects. Through coordinated optimization of size, shape, and surface chemistry, NBM support controlled drug release, improved targeting strategies, and modulation of the tumor microenvironment (TME). This structure-to-function tuning further governs their interaction with biological transport barriers, enabling navigation across abnormal vasculature, dense extracellular matrix, and elevated interstitial fluid pressure. This review critically examines key physicochemical properties (size, shape, and surface chemistry) that govern nano-bio interactions and influence circulation, cellular uptake, biodistribution, immune evasion, and intracellular transport in solid tumors. Emphasis is placed on structure-to-function relationships that link material design with therapeutic performance. The integration of physicochemical optimization with the distinct transport phenotypes of TME highlights that effective NBM require coordinated tuning of multiple parameters rather than merely design adjustments. The synergistic modulation of physicochemical properties can produce adaptive, multifunctional NBM capable of engaging specific TME components and overcoming critical barriers. Together, these insights establish the foundation for rational NBM engineering and provide the mechanistic basis for tumor phenotype focused strategies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.